FDA approves first new schizophrenia drug in decades, KarXT, with milder side effects.

The FDA has approved KarXT, the first new type of drug for schizophrenia in decades. This medication is considered effective and has milder side effects compared to traditional treatments, offering a promising alternative for patients. The approval aligns with earlier expectations from the FDA, marking a significant advancement in managing this mental health condition. NPR's Sydney Lupkin reported on this development.

September 26, 2024
55 Articles

Further Reading